Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Rome
Clinical trial register · Italy

Clinical Trials in Rome, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Rome 56 Milan 50 Naples 27 Bologna 25 Rozzano 21
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS171 Hoffmann-La Roche73 AbbVie56 Merck Sharp & Dohme LLC40 Sanofi30 Clear sponsor filter
Site location
Rome56 Milan50 Naples27 Bologna25 Rozzano21
All 61 locations
Target enrolment
to

Trials with a site in Rome

56 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AbbVie
Observational
200
Rome
2026-06-26
Recruiting
AbbVie
Phase 1
18
Rome
2026-05-20
Recruiting
AbbVie
Phase 2/3
490
Milan, Monza, Fano, Aviano, Rome, Candiolo, Catania, Verona
2025-12-10
Recruiting
AbbVie
Phase 2
180
Rome, Orbassano, Roma
2025-11-25
Recruiting
AbbVie
Phase 3
561
Cona, Florence, Rome, Ancona, Reggio Emilia
2025-11-05
Recruiting
AbbVie
Observational
700
L’Aquila, Milan, Naples, Rome, Genova
2025-09-09
Recruiting
AbbVie
Observational
2,795
Cona, Rome, Bari
2025-09-02
Recruiting
AbbVie
Phase 2/3
854
Rome, Orbassano, Perugia, Roma
2025-08-03
Recruiting
AbbVie
Phase 3
120
San Giovanni Rotondo, Naples, Rome, Trieste
2025-07-28
Active, closed
AbbVie
Phase 3
573
Monserrato, Rozzano, Milan, Naples, Rome, Bologna, Padova, Palermo
2025-06-17
Recruiting
AbbVie
Observational
270
Troina, Pozzilli, Milan, Naples, Turin, Rome, Venice, Ancona
2025-06-04
Recruiting
AbbVie
Observational
700
Milan, Naples, Turin, Rome, Bari, Palermo
2025-03-28
Recruiting
AbbVie
Phase 1/2
252
Meldola, Milan, Rome, Orbassano, Ancona, Bologna
2025-03-06
Recruiting
AbbVie
Phase 3
420
Milan, Rome
2025-02-13
Active, closed
AbbVie
Phase 3
468
Florence, Milan, Naples, Rome, Latina, Pavia, Perugia, Udine
2025-02-10
Recruiting
AbbVie
Observational
1,200
Rozzano, Milan, Naples, Rome, Ancona, Brescia, Campobasso, Catania
2025-01-31
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Recruiting
AbbVie
Phase 2
590
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Rome, Turin, Negrar, Catanzaro
2024-09-04
Recruiting
AbbVie
Phase 3
675
Rome, Bologna
2024-08-19
Recruiting
AbbVie
Phase 3
110
San Giovanni Rotondo, Rome, Messina, Milan
2024-08-08
Recruiting
AbbVie
Phase 3
40
Florence, Milan, Rome
2024-07-08
Active, closed
AbbVie
Phase 3
1,400
Cona, Florence, Rozzano, Naples, Rome, Catania, Milan
2024-06-27
Recruiting
AbbVie
Phase 3
200
L’Aquila, Rozzano, Rome, Milan
2024-06-14
Active, closed
AbbVie
Phase 3
421
Legnano, Turin, Rome, Ancona, Catania
2024-05-19
Active, closed
AbbVie
Phase 2
156
Monserrato, Rome, Negrar
2024-03-23
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Active, closed
AbbVie
Phase 2/3
89
Rozzano, Milan, Naples, Rome, Bologna, Palermo, Roma
2024-01-11
Active, closed
AbbVie
Phase 3
614
Rome, Brescia
2023-12-19
Recruiting
AbbVie
Phase 3
110
Genoa, Naples, Rome, Messina
2023-12-11
Active, closed
AbbVie
Phase 3
122
Florence, Rome, Bologna
2023-11-06
Recruiting
AbbVie
Phase 3
1,500
Florence, L’Aquila, Rozzano, Naples, Rome, Bologna, Brescia, Catania
2023-10-11
Active, closed
AbbVie
Phase 3
1,014
Rome, Ancona, Padova, Pisa
2023-07-25
Active, closed
AbbVie
Phase 3
1,328
Cona, Florence, L’Aquila, Rome, Brescia, Milan, Modena, Pisa
2023-06-21
Active, closed
AbbVie
Observational
1,019
Florence, Rozzano, Milan, Rome, Bari, Bologna, Messina
2023-06-09
Recruiting
AbbVie
Phase 3
450
Milan, Rome, Palermo
2023-05-01
Active, closed
AbbVie
Phase 3
520
Florence, Meldola, Genoa, Rozzano, Milan, Naples, Rome, Mirano
2023-03-15
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
DrugIMGN151
AbbVie
Phase 1
256
Rome, Ancona
2023-01-11
Active, closed
AbbVie
Phase 1
283
Meldola, Milan, Rome, Bologna
2022-10-20
Active, closed
AbbVie
Observational
785
Castellana Grotte, Rozzano, Milan, Naples, Rome, Negrar, Palermo, Pisa
2022-08-15
Recruiting
AbbVie
Phase 3
768
Misterbianco, Milan, Naples, Rome, Bari, Cremona, Messina, Perugia
2022-03-25
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Cona, Milan, Naples, Rome, Negrar, Bari, Chieti, Udine
2022-01-13
Active, closed
AbbVie
Phase 3
527
Bologna, Genoa, Milan, Rho, Rome, Negrar, Cagliari, Palermo
2020-09-30
Active, closed
AbbVie
Phase 3
531
Rozzano, Naples, Rome, Bologna, Reggio Calabria
2020-09-10
Active, closed
AbbVie
Phase 3
330
Bologna, Florence, Rome, Monza, Naples, Turin, Ancona, Bergamo
2020-08-31
Active, closed
AbbVie
Phase 1
85
Rome, Brescia, Meldola
2019-11-08
Active, closed
AbbVie
Phase 1
124
Rome
2019-06-24
Active, closed
AbbVie
Phase 3
964
Modena, Ancona, Catania, Rome, Verona
2019-03-25
Active, closed
AbbVie
Phase 2
270
Bologna, Meldola, Milan, Naples, Rome, Orbassano, Avellino, Parma
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Genoa, Rozzano, Milan, Rho, Rome, Negrar, Bologna, Catania
2018-08-28
Active, closed
AbbVie
Phase 3
1,533
Rome, Rozzano, Ancona, Catania, Milan, Naples
2018-08-09
Active, closed
AbbVie
Phase 3
1,336
Torrette, Genoa, Rozzano, Milan, Rho, Rome, Florence, Negrar
2018-04-09
Active, closed
AbbVie
Phase 3
747
Bologna, Rozzano, Milan, Rome, Negrar, Catania, Catanzaro, Genova
2018-03-21
Active, closed
AbbVie
Phase 3
443
Lecce, Rome, Ancona, Bergamo, Bologna, Genova, Milan, Naples
2017-02-02
Active, closed
AbbVie
Phase 3
950
Bologna, Rozzano, Milan, Rho, Rome, Negrar, Palermo
2017-01-31
Active, closed
AbbVie
Observational
1,446
Milan, Rome, Bologna, Messina, Naples, Palermo, Parma, Pescara
2014-08-28
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Rows per page Showing 1–56 of 56
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/rome

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 56 of those studies with a site in Rome that also match the filters currently applied.

How many clinical trials are recruiting in Rome?

23 of the 56 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 33 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rome), 56 studies
PhaseStudiesRecruitingShare
Phase 3311155.4%
Observational12621.4%
Phase 1518.9%
Phase 2427.1%
Phase 2/3325.4%
Phase 1/2111.8%

Most active sponsors

Lead sponsors with the most studies (Rome)
Lead sponsorStudiesRecruiting
AbbVie5623
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.